mdl-100907 and 9-(aminomethyl)-9-10-dihydroanthracene

mdl-100907 has been researched along with 9-(aminomethyl)-9-10-dihydroanthracene* in 1 studies

Other Studies

1 other study(ies) available for mdl-100907 and 9-(aminomethyl)-9-10-dihydroanthracene

ArticleYear
Potential modes of interaction of 9-aminomethyl-9,10-dihydroanthracene (AMDA) derivatives with the 5-HT2A receptor: a ligand structure-affinity relationship, receptor mutagenesis and receptor modeling investigation.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    The effects of 3-position substitution of 9-aminomethyl-9,10-dihydroanthracene (AMDA) on 5-HT 2A receptor affinity were determined and compared to a parallel series of DOB-like 1-(2,5-dimethoxyphenyl)-2-aminopropanes substituted at the 4-position. The results were interpreted within the context of 5-HT 2A receptor models that suggest that members of the DOB-like series can bind to the receptor in two distinct modes that correlate with the compounds' functional activity. Automated ligand docking and molecular dynamics suggest that all of the AMDA derivatives, the parent of which is a 5-HT 2A antagonist, bind in a fashion analogous to that for the sterically demanding antagonist DOB-like compounds. The failure of the F340 (6.52)L mutation to adversely affect the affinity of AMDA and the 3-bromo derivative is consistent with the proposed modes of orientation. Evaluation of ligand-receptor complex models suggest that a valine/threonine exchange between the 5-HT 2A and D 2 receptors may be the origin of selectivity for AMDA and two substituted derivatives.

    Topics: Animals; Anthracenes; Cattle; Humans; Ligands; Models, Molecular; Molecular Sequence Data; Molecular Structure; Mutagenesis; Protein Binding; Receptor, Serotonin, 5-HT2A; Sequence Alignment; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Structure-Activity Relationship

2008